Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trials
- PMID: 15111472
- PMCID: PMC395813
- DOI: 10.1503/cmaj.1040539
Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trials
References
-
- Choice of an antipsychotic. Med Letter 2003;45:102-4. - PubMed
-
- 2004 safety alert: Zyprexa (olanzapine). Washington: US Food and Drug Administration; 2004 Mar 1. Available: www.fda.gov/medwatch/SAFETY/2004/zyprexa.htm (accessed 2004 Apr 1).
-
- Olanzapine (Zyprexa) and cerebrovascular adverse events in placebo-controlled elderly dementia trials [Dear Healthcare Professional Letter]. Toronto: Elli Lilly Inc.; 2004 Mar 10. Available: www.hc-sc.gc.ca/hpfb-dgpsa/tpd-dpt/zyprexa_hpc_e.pdf (accessed 2004 Apr 1).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources